10-96327514-A-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004088.4(DNTT):āc.921A>Cā(p.Glu307Asp) variant causes a missense change. The variant allele was found at a frequency of 0.00118 in 1,614,130 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0011 ( 0 hom., cov: 32)
Exomes š: 0.0012 ( 2 hom. )
Consequence
DNTT
NM_004088.4 missense
NM_004088.4 missense
Scores
8
11
Clinical Significance
Conservation
PhyloP100: 4.92
Genes affected
DNTT (HGNC:2983): (DNA nucleotidylexotransferase) This gene is a member of the DNA polymerase type-X family and encodes a template-independent DNA polymerase that catalyzes the addition of deoxynucleotides to the 3'-hydroxyl terminus of oligonucleotide primers. In vivo, the encoded protein is expressed in a restricted population of normal and malignant pre-B and pre-T lymphocytes during early differentiation, where it generates antigen receptor diversity by synthesizing non-germ line elements (N-regions) at the junctions of rearranged Ig heavy chain and T cell receptor gene segments. Alternatively spliced transcript variants encoding different isoforms of this gene have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.14372334).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNTT | NM_004088.4 | c.921A>C | p.Glu307Asp | missense_variant | 7/11 | ENST00000371174.5 | NP_004079.3 | |
DNTT | NM_001017520.2 | c.921A>C | p.Glu307Asp | missense_variant | 7/11 | NP_001017520.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNTT | ENST00000371174.5 | c.921A>C | p.Glu307Asp | missense_variant | 7/11 | 1 | NM_004088.4 | ENSP00000360216.2 | ||
DNTT | ENST00000630152.1 | c.921A>C | p.Glu307Asp | missense_variant | 7/11 | 1 | ENSP00000486733.1 |
Frequencies
GnomAD3 genomes AF: 0.00106 AC: 162AN: 152220Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
162
AN:
152220
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00104 AC: 260AN: 251064Hom.: 1 AF XY: 0.00106 AC XY: 144AN XY: 135660
GnomAD3 exomes
AF:
AC:
260
AN:
251064
Hom.:
AF XY:
AC XY:
144
AN XY:
135660
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00119 AC: 1743AN: 1461792Hom.: 2 Cov.: 31 AF XY: 0.00117 AC XY: 851AN XY: 727204
GnomAD4 exome
AF:
AC:
1743
AN:
1461792
Hom.:
Cov.:
31
AF XY:
AC XY:
851
AN XY:
727204
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00106 AC: 162AN: 152338Hom.: 0 Cov.: 32 AF XY: 0.00105 AC XY: 78AN XY: 74494
GnomAD4 genome
AF:
AC:
162
AN:
152338
Hom.:
Cov.:
32
AF XY:
AC XY:
78
AN XY:
74494
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
11
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
22
ExAC
AF:
AC:
109
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2023 | The c.921A>C (p.E307D) alteration is located in exon 7 (coding exon 7) of the DNTT gene. This alteration results from a A to C substitution at nucleotide position 921, causing the glutamic acid (E) at amino acid position 307 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.
REVEL
Uncertain
Sift
Benign
T;.
Sift4G
Benign
T;T
Polyphen
D;D
Vest4
MutPred
Loss of methylation at R305 (P = 0.1524);Loss of methylation at R305 (P = 0.1524);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at